Evaluating the long-term survival benefits of high intensity focused ultrasound ablation for hepatocellular carcinoma with portal vein tumor thrombus: a single center retrospective study

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Cheng SQ, Chen MS, Cai JQ, et al. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 edition). Chin J Dig Surg. 2019;35(4):737–743.
   Google Scholar
• Li S, Wei W, Guo R, et al. Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors. Med Oncol. 2013;30(4):696.
   PubMed Web of Science ®Google Scholar
• Shu-Hong L, Zhi-Xing G, Cheng-Zuo X, et al. Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection. Asian Pac J Cancer Prev. 2013;14(8):4759–4763.
   PubMedGoogle Scholar
• Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona Clinic Liver Cancer Staging System. World J Gastroenterol. 2015;21(36):10327–10335.
   PubMed Web of Science ®Google Scholar
• Wu MC, Tang ZY, Liu YY, et al. Standardization for diagnosis and treatment of primary hepatic carcinoma (2019 edition). Chin J Pract Surg. 2020;40(2):121–138.
   Google Scholar
• Li Z, Mi DH, Yang KH, et al. TACE combined with HIFU for primary hepatic carcinomas: a meta-analysis. J Evid Based Med. 2013;13(5):292–299.
   Google Scholar
• Zhu H, Chen WZ, Li KQ, et al. Preliminary clinical observation on interventional oily chemoembolization guided by US combined with HIFU for treatment of embolization in portal vein. Chin J Ultrasound Med. 2004;20(1):77–79.
   Google Scholar
• Fukuda H, Numata K, Nozaki A, et al. Hyperecho in ultrasound images during high-intensity focused ultrasound ablation for hepatocellular carcinomas. Eur J Radiol. 2011;80(3):e571–e575.
   PubMed Web of Science ®Google Scholar
• Ng KK, Poon RT, Chan SC, et al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg. 2011;253(5):981–987.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu H, Jin C, et al. High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol. 2009;19(2):437–445.
   PubMed Web of Science ®Google Scholar
• Ma R, Zhu H, Gong JP. Survival analysis of transcatheter arterial chemoembolization combined with high intensity-focused ultrasound in the treatment of liver cancer based on propensity score matching method. China Oncol. 2018;28(4):282–289.
   Google Scholar
• Cui L, Liu XX, Jiang Y, et al. Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients. Asian Pac J Cancer Prev. 2012;13(12):6257–6261.
   PubMedGoogle Scholar
• Yang X, Yuan GB, Wang YC, et al. Clinical value of 125I seeds implantation combined with high intensity focused ultrasound for the treatment of portal vein tumor thrombus from hepatocellular carcinoma. Chin J Nucl Med. 2015;35(3):182–185.
   Google Scholar
• Su F, Chen KH, Liang ZG, et al. Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus. Cancer Med. 2018;7(9):4387–4395.
   PubMed Web of Science ®Google Scholar
• Expert committee for the formulation of technical specifications for clinical application of focused ultrasound ablation, Chinese Medical Doctor Association, Lang JH, Expert consensus on technical specifications for clinical application of focused ultrasound ablation (2020 edition). Natl Med J China. 2020;100(13):974–977.
   Google Scholar
• Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235(2):659–667.
   PubMed Web of Science ®Google Scholar
• Huang L, Zhou K, Zhang J, et al. Efficacy and safety of high-intensity focused ultrasound ablation for hepatocellular carcinoma by changing the acoustic environment: microbubble contrast agent (SonoVue) and transcatheter arterial chemoembolization. Int J Hyperthermia. 2019;36(1):244–252.
   PubMed Web of Science ®Google Scholar
• Tang Q, Huang W, Liang J, et al. Efficacy and safety of transarterial chemoembolization in elderly patients of advanced hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study. Front Oncol. 2021;11:646410.
   PubMed Web of Science ®Google Scholar
• Li Y, Li H, Hu H, et al. Efficacy and safety of transcatheter arterial chemoembolization combined with either (125)I seed implantation or apatinib in hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective comparative study. J Cancer Res Ther. 2020;16(7):1691–1697.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Zhang W, Gu JY, et al. Treatment of hepatocellular carcinoma with tumor thrombus with the use of iodine-125 seed strand implantation and transarterial chemoembolization: a propensity-score analysis. J Vasc Interv Radiol. 2018;29(8):1085–1093.
   PubMed Web of Science ®Google Scholar
• Wang GQ, Duan ZP, Zhuang H, et al. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Chin J Hepatol. 2019;27(12):938–961.
   PubMedGoogle Scholar
• Cao Y, Sun T, Guo X, et al. Sorafenib versus apatinib both combined transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a comparative retrospective study. Front Oncol. 2021;11:673378.
   PubMed Web of Science ®Google Scholar
• Zhang XX, Wang C, Zhao W, et al. Efficacy and safety of DEB-TACE combined with apatinib in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. J Interv Radiol. 2021;30(3):282–287.
   Google Scholar
• Munire A, Tan Y, Wang HF, et al. Analysis of therapeutic effect and prognostic factors of IMRT combined with sorafenib in the treatment of hepatocellular carcinoma with portal vein thrombosis. Tianjin Med J. 2021;49(5):514–519.
   Google Scholar
• Ohkoshi-Yamada M, Kamimura K, Shibata O, et al. Efficacy and safety of the radiotherapy for liver cancer: assessment of local controllability and its role in multidisciplinary therapy. Cancers. 2020;12(10):2955.
   PubMed Web of Science ®Google Scholar
• Li Z, Si G, Jiao DC, et al. Portal vein stenting combined with (125)I particle chain implantation followed by as(2)O(3) in the treatment of hepatocellular carcinoma with portal vein tumour thrombus. Biomed Res Int. 2020;2020:1–7.
   Web of Science ®Google Scholar
• Liang J, Ge NJ, Guo XL, et al. Clinical analysis of percutaneous radiofrequency ablation combined with TACE in treatment of hepatocellular carcinoma with type III portal vein tumor thrombus. J Hepatobil Surg. 2020;28(5):345–348.
   Google Scholar
• Yuan G, Cheng X, Li Q, et al. Safety and efficacy of camrelizumab combined with apatinib for advanced hepatocellular carcinoma with portal vein tumor thrombus: a multicenter retrospective study. Onco Targets Ther. 2020;13:12683–12693.
   PubMed Web of Science ®Google Scholar
• Ni JY, Sun HL, Luo JH, et al. Transarterial chemoembolization and sorafenib combined with microwave ablation for advanced primary hepatocellular carcinoma: a preliminary investigation of safety and efficacy. Cancer Manag Res. 2019;11:9939–9950.
   PubMed Web of Science ®Google Scholar
• Choi JH, Chung WJ, Bae SH, et al. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemother Pharmacol. 2018;82(3):469–478.
   PubMed Web of Science ®Google Scholar
• Jia Z, Jiang G, Tian F, et al. A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis. Saudi J Gastroenterol. 2016;22(5):353–359.
   PubMed Web of Science ®Google Scholar
• Lee SU, Park JW, Kim TH, et al. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol. 2014;190(9):806–814.
   PubMed Web of Science ®Google Scholar
• Zhang ZM, Lai EC, Zhang C, et al. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg. 2015;20:8–16.
   PubMed Web of Science ®Google Scholar
• Li CX, Zhang H, Wu XF, et al. Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging. Chin J Surg. 2021;59(2):134–143.
   PubMedGoogle Scholar
• Wei J, Cui W, Fan W, et al. Unresectable hepatocellular carcinoma: transcatheter arterial chemoembolization combined with microwave ablation vs. combined with cryoablation. Front Oncol. 2020;10:1285.
   PubMed Web of Science ®Google Scholar
• Zhu BR, Li J, Gai LH, et al. Clinical analysis of focused ultrasound ablation combined with TACE in the treatment of larger than 10 cm hepatocellular carcinoma. Chin J Interv Radiol. 2016;4(2):86–90.
   Google Scholar
• Cao H, Xu Z, Long H, et al. Transcatheter arterial chemoembolization in combination with high-intensity focused ultrasound for unresectable hepatocellular carcinoma: a systematic review and meta-analysis of the Chinese literature. Ultrasound Med Biol. 2011;37(7):1009–1016.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang H, Wei L, et al. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget. 2017;8(9):15101–15113.
   PubMedGoogle Scholar
• Wang M, Wang Y, Feng X, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China North areas: experience of the Chinese National Cancer Center. Int J Infect Dis. 2017;65:15–21.
   PubMed Web of Science ®Google Scholar
• Prevention of Infection Related Cancer (PIRCA) Group, Specialized Committee of Cancer Prevention and Control, Chinese Preventive Medicine Association, et al. Strategies of primary prevention of liver cancer in China: Expert Consensus (2018). Zhonghua Zhong Liu Za Zhi. 2018;40(7):550–557.
   PubMedGoogle Scholar
• Guidelines for the clinical application of new anti-tumor drugs (2018 edition). J Multidisciplinary Cancer Manage. 2019;5(1):35–54.
   Google Scholar
• Ajit Y, Sudarsan H, Saumya G, et al. Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival. Oman Med J. 2014;29(6):430–436.
   PubMedGoogle Scholar
• Kim J, Chung DJ, Jung SE, et al. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy—preliminary observations. Br J Radiol. 2012;85(1018):e940–e946.
   PubMed Web of Science ®Google Scholar
• Chan AC, Cheung TT, Fan ST, et al. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann Surg. 2013;257(4):686–692.
   PubMed Web of Science ®Google Scholar
• Yang M, Fang Z, Yan Z, et al. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial. J Cancer Res Clin Oncol. 2014;140(2):211–219.
   PubMed Web of Science ®Google Scholar
• Cheng SQ, Wu MC, Cheng HY, et al. Growing features of the tumor thrombus of portal vein in hepatocellular carcinoma: report of 130 cases. Chin J Curr Adv Gen Surg. 2003;2:103–105.
   Google Scholar
• Zhang B. Observation of the local efficacy of high intensity focused ultrasound combined 125I implantation therapy in the treatment of portal vein tumor thrombus[D]. Chongqing: Chongqing Medical University; 2016.
   Google Scholar
• Strunk HM, Lützow C, Henseler J, et al. Mesenteric vessel patency following HIFU therapy in patients with locally invasive pancreatic cancer. Ultraschall Med. 2018;39(6):650–658.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhu H, Zhou K, et al. Effects of high-intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreatic cancer. Oncol Lett. 2020;19(6):3839–3850.
   PubMed Web of Science ®Google Scholar
• Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93(8):890–895.
   PubMed Web of Science ®Google Scholar